NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.

Scientists in China have found a new coronavirus in bats that could possibly infect humans, but the risk remains low for now.

In its Q3 2022 filing with the US Securities and Exchange Commission, Lucira noted that some of the delays were the result of a lack of clinical data. The firm at one point had to amend its ...

The new virus, called HKU5-CoV-2, was identified by researchers at the Wuhan Institute of Virology, which gained notoriety ...

Long COVID is the chronic manifestation of lasting symptoms of SARS-CoV-2 infection that can last for at least 3 months, with shortness of breath and system inefficiency often remaining central issues ...

Hospitalisations and deaths attributed to COVID have dropped significantly since a peak in 2022. But a new variant could ...

Anxiety and mood disorders are more prevalent among patients after COVID-19 critical illness vs after severe pneumonia unrelated to COVID-19.

Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...

A new mpox variant, clade 1b, is spreading rapidly in the DRC, with increased human-to-human transmission and risks for ...

For a majority of people, the COVID vaccine doesn’t cause adverse health effects — but a small percentage experience chronic ...

The CDC said in a statement on Monday that it does not believe the new coronavirus found in bats poses a concern to public health currently.

Receptors on B and T cells hint at what the immune system is targeting. An AI approach called Mal-ID developed increases diagnostic accuracy, particularly for autoimmune diseases.